Market Cap

10x Genomics, Inc. Market Capitalization:

$4.30 Billion

USD as of Jan. 1, 2023

business 10x Genomics, Inc. Company Profile

10x Genomics, Inc. Main Stock Listing

show_chart NASDAQ: TXG

Market Capitalization History of 10x Genomics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Health Information Services
Company Market Cap (USD)
Veeva Systems Inc. $25.12 B
M3, Inc. $17.56 B
Change Healthcare Inc. $9.03 B
Signify Health, Inc. $8.38 B
Inovalon Holdings, Inc. $6.37 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of 10x Genomics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $4.30 B -60.54%
Jan. 1, 2022 $10.90 B -43.75%
Jan. 1, 2021 $19.37 B 87.27%
Jan. 1, 2020 $10.35 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

10x Genomics, Inc. Categories

United States languages Healthcare languages Health Information Services
United States Healthcare United States Health Information Services

Stocks & Indices

10x Genomics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: TXG

Stock: FSX: 1KJ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.